Mission-critical activities of HHS will continue during the Democrat-led government shutdown. Please use this site as a resource as the Trump Administration works to reopen the government for the American people.

Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States Strengths and Challenges Assessment to

Lambrou, A.S., Redd, J.T., Steward, M.A., et al. (2022). Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency Use. Disaster Medicine and Public Health Preparedness. 14;1-32.
The authors of this article conducted a descriptive analysis from three sites at medical centers in the U.S. supported by the National Disaster Medical System to examine the monoclonal antibody infusion site process during the COVID-19 pandemic. The authors discuss several successes and challenges in implementing these sites.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.